Investing time and effort into your career through multiple channels will help you earn the pay and recognition—and derive the pleasure and satisfaction—that you deserve. This is the third article in a series from APA’s Women Psychiatrists Caucus.

Should psychotherapy be approved and prescribed like a drug? The U.S. Food and Drug Administration (FDA) seems to think so. On March 30, 2024, the FDA’s Center for Devices and Radiological Health approved a cognitive-behavioral therapy (CBT)–based digital treatment for major depressive disorder called Rejoyn.

Join your colleagues at the Hilton Baltimore Inner Harbor hotel Sept. 26–28 for the next Mental Health Services Conference, which brings together psychiatrists and other mental health professionals to collaborate on practical ways to influence systems-level change for their patients. Learn more and register